{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Tampa&page=15&state=Florida", "query": { "state": "Florida", "city": "Tampa", "page": 15 }, "page_size": 10 }, "pagination": { "page": 15, "page_size": 10, "total_count": 9115, "total_pages": 912, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Tampa&page=16&state=Florida&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Tampa&page=14&state=Florida&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-31T17:48:44.303Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01037218", "title": "Treatment of Erectile Dysfunction II", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Erectile Dysfunction" ], "interventions": [ { "name": "Udenafil", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Warner Chilcott", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "MALE", "summary": "19 Years and older · Male only" }, "enrollment_count": 601, "start_date": "2009-09", "completion_date": "2010-04", "has_results": true, "last_update_posted_date": "2015-06-19", "last_synced_at": "2026-10-31T17:48:44.303Z", "location_count": 40, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Tempe, Arizona + 36 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Chino", "state": "California" }, { "city": "Tarzana", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01037218" }, { "nct_id": "NCT00454688", "title": "Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Irritable Bowel Syndrome" ], "interventions": [ { "name": "Asimadoline", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tioga Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "79 Years", "sex": "ALL", "summary": "18 Years to 79 Years" }, "enrollment_count": 596, "start_date": "2006-08", "completion_date": "2007-12", "has_results": false, "last_update_posted_date": "2011-10-18", "last_synced_at": "2026-10-31T17:48:44.303Z", "location_count": 112, "location_summary": "Huntsville, Alabama • Pheonix, Arizona • Phoenix, Arizona + 96 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Pheonix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00454688" }, { "nct_id": "NCT03112603", "title": "A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Graft-versus-host Disease (GVHD)" ], "interventions": [ { "name": "Ruxolitinib", "type": "DRUG" }, { "name": "Extracorporeal photopheresis (ECP)", "type": "DRUG" }, { "name": "Low-dose methotrexate (MTX)", "type": "DRUG" }, { "name": "Mycophenolate mofetil (MMF)", "type": "DRUG" }, { "name": "mechanistic Target of Rapamycin (mTOR) inhibitors (everolimus or sirolimus)", "type": "DRUG" }, { "name": "Infliximab", "type": "DRUG" }, { "name": "Rituximab", "type": "DRUG" }, { "name": "Pentostatin", "type": "DRUG" }, { "name": "Imatinib", "type": "DRUG" }, { "name": "Ibrutinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 330, "start_date": "2017-06-29", "completion_date": "2022-12-15", "has_results": true, "last_update_posted_date": "2025-08-12", "last_synced_at": "2026-10-31T17:48:44.303Z", "location_count": 38, "location_summary": "Tucson, Arizona • Duarte, California • La Jolla, California + 28 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03112603" }, { "nct_id": "NCT03898479", "title": "Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Alopecia Areata" ], "interventions": [ { "name": "CTP-543", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sun Pharmaceutical Industries, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 1000, "start_date": "2019-04-04", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2025-10-22", "last_synced_at": "2026-10-31T17:48:44.303Z", "location_count": 72, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 61 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Rogers", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03898479" }, { "nct_id": "NCT02457546", "title": "The EVICEL® Neurosurgery Phase III Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cerebrospinal Fluid Leak" ], "interventions": [ { "name": "EVICEL Fibrin Sealant", "type": "BIOLOGICAL" }, { "name": "Hydrogel sealant", "type": "DEVICE" } ], "intervention_types": [ "BIOLOGICAL", "DEVICE" ], "sponsor": "Ethicon, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 234, "start_date": "2015-07-01", "completion_date": "2017-10-12", "has_results": true, "last_update_posted_date": "2019-01-10", "last_synced_at": "2026-10-31T17:48:44.303Z", "location_count": 13, "location_summary": "Los Angeles, California • Sacramento, California • Jacksonville, Florida + 10 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02457546" }, { "nct_id": "NCT02994654", "title": "CONTINUED ACCESS PROTOCOL: Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Burns" ], "interventions": [ { "name": "ReCell", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Avita Medical", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": null, "sex": "ALL", "summary": "5 Years and older" }, "enrollment_count": 12, "start_date": "2016-10", "completion_date": "2018-09", "has_results": true, "last_update_posted_date": "2024-07-30", "last_synced_at": "2026-10-31T17:48:44.303Z", "location_count": 6, "location_summary": "Phoenix, Arizona • Washington D.C., District of Columbia • Tampa, Florida + 3 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Tampa", "state": "Florida" }, { "city": "Winston-Salem", "state": "North Carolina" }, { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT02994654" }, { "nct_id": "NCT05004662", "title": "Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Smoking Cessation" ], "interventions": [ { "name": "Smartphone-delivered automated treatment", "type": "BEHAVIORAL" }, { "name": "Nicotine patch", "type": "DRUG" }, { "name": "Counseling", "type": "BEHAVIORAL" }, { "name": "Nicotine lozenge", "type": "DRUG" } ], "intervention_types": [ "BEHAVIORAL", "DRUG" ], "sponsor": "H. Lee Moffitt Cancer Center and Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 502, "start_date": "2021-12-01", "completion_date": "2025-08-19", "has_results": true, "last_update_posted_date": "2026-09-24", "last_synced_at": "2026-10-31T17:48:44.303Z", "location_count": 1, "location_summary": "Tampa, Florida", "locations": [ { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05004662" }, { "nct_id": "NCT00645086", "title": "Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets to 7 Days of Clarithromycin Immediate-Release Tablets for the Treatment of Exacerbation of Chronic Bronchitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB)." ], "interventions": [ { "name": "clarithromycin extended-release tablets", "type": "DRUG" }, { "name": "clarithromycin immediate-release tablets", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Abbott", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 465, "start_date": "2002-12", "completion_date": null, "has_results": false, "last_update_posted_date": "2008-03-27", "last_synced_at": "2026-10-31T17:48:44.303Z", "location_count": 135, "location_summary": "Birmingham, Alabama • Columbiana, Alabama • Hoover, Alabama + 122 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Columbiana", "state": "Alabama" }, { "city": "Hoover", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00645086" }, { "nct_id": "NCT06104683", "title": "A Study of Pirtobrutinib (LY3527727 [LOXO-305]) Versus Placebo in Participants With Relapsing Multiple Sclerosis", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Relapsing Multiple Sclerosis", "Multiple Sclerosis" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Pirtobrutinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Loxo Oncology, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 0, "start_date": "2024-05-01", "completion_date": "2026-02-13", "has_results": false, "last_update_posted_date": "2024-03-27", "last_synced_at": "2026-10-31T17:48:44.303Z", "location_count": 3, "location_summary": "Tampa, Florida • Houston, Texas • Seattle, Washington", "locations": [ { "city": "Tampa", "state": "Florida" }, { "city": "Houston", "state": "Texas" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT06104683" }, { "nct_id": "NCT00402246", "title": "CONNECT Study - Clinical Evaluation Of Remote NotificatioN to rEduCe Time to Clinical Decision", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Arrhythmia", "Tachycardia", "Atrial Fibrillation", "Ventricular Fibrillation" ], "interventions": [ { "name": "Remote Management", "type": "OTHER" }, { "name": "In-Office Care", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Medtronic Cardiac Rhythm and Heart Failure", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2009, "start_date": "2006-11", "completion_date": "2009-09", "has_results": true, "last_update_posted_date": "2011-02-25", "last_synced_at": "2026-10-31T17:48:44.303Z", "location_count": 127, "location_summary": "Mobile, Alabama • Mesa, Arizona • Scottsdale, Arizona + 124 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Fort Smith", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00402246" } ] }